fda import alert glp-1 semaglutide tirzepatide green list Demurs on Compounding Fight, Debuts Consumer 'Green List' Instead FDA creates "green list" to

Weight loss on tirzepatide happens gradually over several months

almost 100,000 patients paying privately for Wegovy alone in Denmark

Meaning This analysis of patient electronic health record data suggests an increased risk of optic nerve disorders associated with semaglutide or tirzepatide in patients with type 2 diabetes, highlighting the need for close monitoring of these conditions

A very low calorie diet also raises the risk of gallstones, electrolyte imbalance, and heart rhythm problems, which is exactly why it should never be attempted without medical supervision

This includes the telehealth consultation, the prescription (if approved by the evaluating clinician), and medication delivery

However, individual responses vary significantly based on age, baseline metabolic health, genetics, and compliance with nutrition and activity protocols